0001104659-22-027398.txt : 20220225 0001104659-22-027398.hdr.sgml : 20220225 20220225171712 ACCESSION NUMBER: 0001104659-22-027398 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220225 DATE AS OF CHANGE: 20220225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin Tami Tillotson CENTRAL INDEX KEY: 0001539494 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35518 FILM NUMBER: 22681935 MAIL ADDRESS: STREET 1: C/O SUPERNUS PHARMACEUTICALS, INC. STREET 2: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SUPERNUS PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001356576 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-838-2500 MAIL ADDRESS: STREET 1: 9715 KEY WEST AVENUE CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: SUPERNUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060317 4/A 1 tm227764-5_4aseq1.xml OWNERSHIP DOCUMENT X0306 4/A 2022-02-22 2022-02-24 0 0001356576 SUPERNUS PHARMACEUTICALS, INC. SUPN 0001539494 Martin Tami Tillotson C/O SUPERNUS PHARMACEUTICALS, INC. 9715 KEY WEST AVENUE ROCKVILLE MD 20850 0 1 0 0 Sr. V.P., Regulatory Affairs Common Stock 87220 D Employee Stock Option (Right to Buy) 32.20 2022-02-22 4 A 0 18000 0 A 2032-02-22 Common Stock 18000 18000 D Restricted Stock Units 2022-02-22 4 A 0 3000 0 A Common Stock 3000 3000 D Includes an aggregate of 894 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan subsequent to the date of the Reporting Person's most recent filing on Form 4. The option vests in four equal annual installments beginning on February 22, 2023. Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting. The Reporting Person is amending Form 4 filed on February 24, 2022 to reflect that these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on February 22, 2023, rather than such vesting occurring entirely on February 22, 2023. /s/ Timothy C. Dec, as attorney-in-fact 2022-02-25